InvestorsHub Logo
Followers 6
Posts 2507
Boards Moderated 0
Alias Born 07/21/2016

Re: BioNewton post# 61622

Friday, 01/20/2017 3:33:16 PM

Friday, January 20, 2017 3:33:16 PM

Post# of 144813
That makes no sense seeing how one of the primary endpoints would be length of effectiveness on a wide range of patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News